FDA
-
-
-
-
-
-
-
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
-
-
-
-
-
-
-
SINTX Technologies raises $5 million through private placement
-
-
-
-
-
-
-
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
-
-
-
-
-
-
-
SINTX Technologies launches OsseoSculpt biologic for foot surgeries
-
-
-
-
-
-
-
SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride
-
-
-
-
-
-
-
SINTX Technologies (SINT) Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization
-
-
-
-
-
-
-
SINTX Technologies (SINT) To Explore Strategic Opportunities
-
334,271 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


